KeyBanc analyst Matthew Mishan upgraded Becton Dickinson to Overweight from Sector Weight with a $304 price target. After five years of being "fully range-bound," Becton Dickinson shares are "finally capable of sustaining a breakout" given more consistent execution toward its long-term financial targets and a "reasonable" valuation, the analyst tells investors in a research note. The firm sees see "several positive drivers" supporting durable 5.5% revenue growth the next several years, with Alaris representing a potential source of upside.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BDX:
- Becton Dickinson added to ‘Tactical Outperform’ list at Evercore ISI
- Becton Dickinson names Michelle Quinn as general counsel
- Becton Dickinson receives FDA clearance for BD Vaginal Panel
- Moody’s to appoint Vincent Forlenza chairman on April 18
- Becton Dickinson announces FDA market approval for BD Onclarity HPV Assay